Eustatia-Rutten Carmen F A, Corssmit Eleonora P M, Heemstra Karen A, Smit Johannes W A, Schoemaker Rik C, Romijn Johannes A, Burggraaf Jacobus
Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, The Netherlands.
J Clin Endocrinol Metab. 2008 Jul;93(7):2835-41. doi: 10.1210/jc.2008-0080. Epub 2008 Apr 8.
Knowledge on the relationship between the autonomic nervous system and subclinical hyperthyroidism is mainly based upon cross-sectional studies in heterogeneous patient populations, and the effect of restoration to euthyroidism in subclinical hyperthyroidism has not been studied.
We investigated the long-term effects of exogenous subclinical hyperthyroidism on the autonomic nervous system and the potential effects of restoration of euthyroidism.
This was a prospective single-blinded, placebo-controlled, randomized trial.
The study was performed at a university hospital.
A total of 25 patients who were on more than 10-yr TSH suppressive therapy after thyroidectomy was examined.
Patients were studied at baseline and subsequently randomized to a 6-month thyroid hormone substitution regimen to obtain either euthyroidism or maintenance of the subclinical hyperthyroid state.
Urinary excretion of catecholamines and heart rate variability were measured. Baseline data of the subclinical hyperthyroidism patients were compared with data obtained in patients with hyperthyroidism and controls.
Urinary excretion of norepinephrine and vanillylmandelic acid was higher in the subclinical hyperthyroidism patients compared with controls and lower compared with patients with overt hyperthyroidism. Heart rate variability was lower in patients with hyperthyroidism, intermediate in subclinical hyperthyroidism patients, and highest in the healthy controls. No differences were observed after restoration of euthyroidism.
Long-term exogenous subclinical hyperthyroidism has effects on the autonomic nervous system measured by heart rate variability and urinary catecholamine excretion. No differences were observed after restoration to euthyroidism. This may indicate the occurrence of irreversible changes or adaptation during long-term exposure to excess thyroid hormone that is not remedied by 6-month euthyroidism.
关于自主神经系统与亚临床甲状腺功能亢进之间关系的知识主要基于对异质患者群体的横断面研究,且尚未研究亚临床甲状腺功能亢进恢复至甲状腺功能正常的效果。
我们研究了外源性亚临床甲状腺功能亢进对自主神经系统的长期影响以及恢复甲状腺功能正常的潜在影响。
这是一项前瞻性单盲、安慰剂对照、随机试验。
该研究在一家大学医院进行。
共检查了25例甲状腺切除术后接受超过10年促甲状腺激素抑制治疗的患者。
在基线时对患者进行研究,随后随机分为6个月的甲状腺激素替代治疗方案,以实现甲状腺功能正常或维持亚临床甲状腺功能亢进状态。
测量儿茶酚胺的尿排泄量和心率变异性。将亚临床甲状腺功能亢进患者的基线数据与甲状腺功能亢进患者和对照组的数据进行比较。
与对照组相比,亚临床甲状腺功能亢进患者去甲肾上腺素和香草扁桃酸的尿排泄量更高,与显性甲状腺功能亢进患者相比更低。甲状腺功能亢进患者的心率变异性较低,亚临床甲状腺功能亢进患者居中,健康对照组最高。恢复甲状腺功能正常后未观察到差异。
长期外源性亚临床甲状腺功能亢进对通过心率变异性和尿儿茶酚胺排泄量测量的自主神经系统有影响。恢复甲状腺功能正常后未观察到差异。这可能表明在长期暴露于过量甲状腺激素期间发生了不可逆的变化或适应,6个月的甲状腺功能正常状态无法纠正这种情况。